They need to amend page 18 and remove the reference to CSL 112 as a candidate product currently in phase III trials.
Just highlight and delete.
Ann: Shareholder Information Meetings, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$281.34 |
Change
1.240(0.44%) |
Mkt cap ! $135.9B | |||
| Open | High | Low | Value | Volume |
| $283.65 | $283.88 | $279.40 | $153.6M | 546.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 350 | $280.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $281.40 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$281.02 |
Change
1.240 ( 1.07 %) |
||||
| Open | High | Low | Volume | ||
| $283.47 | $283.88 | $279.40 | 479951 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| CSL (ASX) Chart |